Dibucaine and lidocaine are both amide-type local anesthetics that numb tissue by blocking sodium channels, but they sit at very different points on the spectrum of potency, toxicity, and clinical use. Dibucaine is roughly 15 to 20 times more potent than lidocaine on a milligram-for-milligram basis, which sounds like an advantage until you realize that same potency makes it far more dangerous if misused. In practice, lidocaine is one of the most widely used local anesthetics in the world, while dibucaine has been relegated almost entirely to over-the-counter topical ointments for hemorrhoids and minor skin irritation.
The Shared Mechanism
Both drugs work by plugging the pore of voltage-gated sodium channels in nerve cell membranes. When a nerve fires, sodium ions rush inward through these channels to propagate the electrical signal that your brain reads as sensation. Dibucaine and lidocaine physically wedge themselves into the channel’s inner pore, interacting with key amino acid residues along the channel wall and preventing sodium from flowing through.1PubMed Central. Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants The drug molecule sits between two aromatic residues that line one face of the pore, essentially forming a plug that is the right size and shape to block ion traffic.2British Journal of Anaesthesia. Molecular mechanisms of local anaesthetic action on voltage-gated sodium channels No sodium flow, no nerve signal, no pain. The basic mechanism is the same for every local anesthetic in the amide family.
Where dibucaine and lidocaine diverge is in how tightly and how long they grip that channel. Dibucaine has a bulkier molecular structure with a longer lipophilic side chain, which means it binds more avidly to the sodium channel and dissociates more slowly. That translates to a longer duration of action and greater potency per dose. Lidocaine, by contrast, has a more compact structure that binds and unbinds relatively quickly, making it shorter-acting but also faster in onset and easier to control.
Why Lidocaine Dominates Clinical Use
Lidocaine is the workhorse of local anesthesia. Dentists inject it before filling a cavity. Emergency physicians use it to numb lacerations before stitching. Surgeons infiltrate it around incision sites. It is available in injectable solutions, topical creams, patches, gels, sprays, and even intravenous formulations. Its moderate potency, rapid onset, predictable duration of about one to two hours, and well-understood safety profile make it the default choice for procedures that need reliable, temporary nerve block.
Dibucaine occupies a much narrower niche. In the United States, the FDA withdrew it from use as a spinal anesthetic decades ago because its high potency made the margin between an effective dose and a toxic dose uncomfortably thin.3PubMed Central. Local anaesthetic systemic toxicity following oral ingestion in a child: Revisiting dibucaine Today it persists mainly as a 1% topical ointment sold without a prescription for temporary relief of pain and itching from hemorrhoids and other anorectal conditions.4DailyMed. DIBUCAINE TOPICAL ANESTHETIC 1% HEMORRHOIDAL- dibucaine ointment In parts of Asia and Europe, where it goes by the name cinchocaine, it also appears in ear drops and some topical preparations, but injectable use is essentially extinct.
The practical upshot is that most people encounter dibucaine only at the pharmacy shelf next to other hemorrhoid creams, while lidocaine is the drug they receive in a medical setting whenever a clinician needs to numb something quickly.
The Potency Gap and What It Means for Toxicity
The same property that makes dibucaine a powerful pain reliever on tissue surfaces makes it extremely dangerous if absorbed into the bloodstream in any significant quantity. Dibucaine is far more potent than lidocaine, which means that a much smaller amount can cause serious toxicity.5The Journal of Emergency Medicine. Are One or Two Dangerous? Lidocaine and Topical Anesthetic Exposures in Children Both drugs, once they reach the central nervous system and heart in toxic concentrations, can cause the same cascade of problems: dizziness, blurred vision, seizures, dangerous heart rhythm disturbances, and potentially cardiac arrest.
For lidocaine, reaching those toxic levels typically requires a substantial overdose, a botched injection technique that sends the drug directly into a blood vessel, or application of large amounts of topical lidocaine to broken skin. The threshold is high enough that lidocaine has an excellent safety record across millions of uses per year. Dibucaine, on the other hand, can reach dangerous blood levels from a surprisingly small exposure. A case report describes a seven-year-old child who accidentally swallowed dibucaine ear drops and developed double vision, dizziness, abnormal heart rhythms, and a right bundle branch block.6PubMed Central. Local anaesthetic systemic toxicity following oral ingestion in a child: Revisiting dibucaine
A Serious Risk for Children
Pediatric poisoning from dibucaine has been a recurring concern in the medical literature, and the pattern is grimmer than with most other local anesthetics. Because dibucaine ointment is sold over the counter, it can end up in households where young children may access it. In multiple reported cases of accidental ingestion by children, the outcomes have been devastating. A review of three fatal cases found that children who swallowed relatively small amounts of dibucaine developed seizures and lethal cardiac arrhythmias.7PubMed. Fatal accidental dibucaine poisoning in children Another report described dibucaine as one of the most potent and consequently most toxic amide anesthetics available, noting that all reported consequential ingestions in children at the time of publication had resulted in death.8Pediatric Emergency Care. Severe Central Nervous System and Cardiovascular Toxicity in a Pediatric Patient After Ingestion of an Over-the-Counter Local Anesthetic
Lidocaine is not harmless in children either, and oral ingestion of concentrated lidocaine products like viscous solutions can be dangerous. But the margin of safety is wider. The amount of lidocaine a child would need to swallow to reach lethal blood levels is substantially larger than the corresponding amount of dibucaine. This disparity has led some toxicologists and emergency physicians to argue that dibucaine’s continued availability as an over-the-counter product deserves closer regulatory scrutiny, given that safer alternatives exist for the same indications.
Allergic Reactions and Skin Sensitization
Both dibucaine and lidocaine belong to the amide class of local anesthetics, which as a group cause far fewer allergic reactions than the older ester class. Ester anesthetics like benzocaine and procaine break down into a metabolite that is a well-known allergen, which is why allergic contact dermatitis from those drugs is relatively common.9ResearchGate. The new Italian SIDAPA Baseline Series for patch testing (2023) Amides do not produce that metabolite, so true allergic reactions are rarer.
Rarer does not mean zero, though, and there is an interesting asymmetry between these two drugs when it comes to skin sensitization. A patch-testing study of over 600 dermatology patients found that among the 25 who tested positive to at least one local anesthetic, dibucaine was by far the most common culprit, triggering positive reactions in 20 of those 25 patients. Lidocaine sensitization was seen in only two.10PubMed. Sources of sensitization, cross-reactions, and occupational sensitization to topical anaesthetics among general dermatology patients This likely reflects dibucaine’s chemical structure and its tendency to linger on the skin longer due to stronger tissue binding. If you have had an itchy, red, or blistered reaction to a hemorrhoid ointment, dibucaine allergy is a plausible explanation worth raising with a dermatologist.
Cross-reactivity between dibucaine and lidocaine is uncommon but not impossible. Some patients in the same study reacted to both amide and ester anesthetics simultaneously, suggesting that individual immune systems occasionally respond to structural features shared across the local anesthetic family. If you have a confirmed allergy to one amide anesthetic, your clinician will usually skin-test before using another one, rather than assuming you are fine.
Lidocaine’s Quirk in Spinal Anesthesia
One area where lidocaine has a notable downside involves spinal anesthesia, where a small dose of local anesthetic is injected into the cerebrospinal fluid to numb the lower body for surgery. Lidocaine was once the go-to drug for short spinal blocks because of its rapid onset and brief duration, but over time a problem emerged: transient neurologic symptoms, or TNS. Patients would recover from surgery only to develop burning or aching pain in the buttocks and legs within 24 hours, lasting up to several days before resolving on its own.
A Cochrane review pooling data from 15 trials and over 1,400 patients found that lidocaine carried a roughly sevenfold higher risk of TNS compared to other spinal anesthetics like bupivacaine and prilocaine.11Cochrane Database of Systematic Reviews. Local anaesthetics for spinal anaesthesia for transient neurologic symptoms The symptoms were self-limiting and did not appear to cause lasting nerve damage, but they were painful enough to make patients miserable and prompted many anesthesiologists to switch away from spinal lidocaine for routine cases.
More recent data suggests the picture may be evolving. A 2025 study of over 1,000 patients receiving lidocaine spinal anesthesia for joint surgery found that only about 0.2% developed TNS, with symptoms that were mild and resolved within two to three days.12Regional Anesthesia & Pain Medicine. Incidence of transient neurologic symptoms in patients receiving lidocaine spinal anesthesia for outpatient joint arthroplasty The authors attributed the lower rate to modern multimodal pain management protocols used alongside the spinal block. Whether this means lidocaine can make a comeback in spinal anesthesia or whether anesthesiologists will continue to prefer longer-acting alternatives remains an open question.
Dibucaine, for its part, is not part of this conversation at all. Its withdrawal from spinal use predates the TNS controversy by years, driven by the toxicity concerns described above rather than by any specific neurologic complication.
Duration of Action and Practical Trade-Offs
For topical use, where both drugs are available without a prescription in various formulations, the duration difference is the most noticeable practical distinction. Lidocaine creams and patches typically provide numbness lasting anywhere from 30 minutes to about two hours depending on the formulation and the area of skin. Dibucaine ointment tends to produce longer-lasting numbness from a single application, which is part of its appeal for hemorrhoid relief where you want sustained comfort.
That longer duration comes directly from dibucaine’s tighter binding and higher lipid solubility. The drug sinks deeper into the tissue and stays put longer before being cleared. For a localized surface application where systemic absorption is minimal, this is a genuine advantage. You apply it less often and get more hours of relief. The catch is everything discussed above: if that same property manifests as systemic absorption, say through broken skin or mucosal membranes, the drug lingers in the bloodstream longer too, and at a more dangerous effective concentration.
Lidocaine’s shorter duration is less convenient for something like hemorrhoid care, but it also means the drug clears your system faster if something goes wrong. For topical pain relief on intact skin, the risk difference between the two is small enough that either product is considered safe when used as directed. The safety gap widens dramatically when the products are used off-label, applied to large areas of damaged skin, or accidentally ingested.
The Dibucaine Number
If you have encountered the word “dibucaine” in a medical context that had nothing to do with pain relief, it was probably in reference to the dibucaine number, a laboratory test used in anesthesiology. The test measures how effectively dibucaine inhibits a blood enzyme called pseudocholinesterase (also known as butyrylcholinesterase). This enzyme breaks down certain muscle-relaxing drugs used during general anesthesia, most notably succinylcholine.
Some people carry genetic variants that produce an abnormal form of pseudocholinesterase. In these individuals, succinylcholine is not broken down at the normal rate, which means muscle paralysis can last dangerously long after surgery. The dibucaine number helps identify who has the normal enzyme versus an atypical variant. A normal dibucaine number is around 80, meaning dibucaine inhibits about 80% of the enzyme’s activity in a test tube. People with certain genetic variants score much lower, around 20 to 30, signaling that their enzyme behaves differently and they are at risk for prolonged paralysis if given succinylcholine.
The test has nothing to do with actually giving a patient dibucaine. It is purely a laboratory reagent in this context. But it is one of the more common reasons dibucaine’s name appears in hospital records and medical textbooks, which can be confusing if you are trying to understand what the drug itself does.
Lidocaine in the Water
Because lidocaine is used in such enormous quantities worldwide, it has become one of the pharmaceutical compounds that shows up in environmental water monitoring. Lidocaine has been detected in rivers, lakes, and wastewater treatment plant water at concentrations ranging from a few nanograms per liter up to about 2 micrograms per liter.13PubMed Central. Acute toxicity of local anesthetics used for humans and other animals in the larvae of marine crustacean, red-clawed crab Chiromantes haematocheir The drug enters waterways through industrial waste, human excretion, and disposal of unused medications. Research into whether these trace concentrations affect aquatic organisms is still in early stages, with some laboratory studies examining toxicity in crustacean larvae. Dibucaine, being used in far smaller quantities globally, is not a significant environmental concern by comparison. This is one of those cases where a drug’s very popularity creates a secondary issue that its less-used cousin avoids simply by being obscure.
Choosing Between Them for Over-the-Counter Use
If you are standing in a pharmacy aisle looking at topical pain relief products and see both lidocaine and dibucaine on the shelf, the decision comes down to a few practical considerations. For hemorrhoid relief specifically, dibucaine ointment has a long track record and its longer duration can mean fewer applications per day. Lidocaine-based products are available in more formulations and for a wider range of uses, from sunburn to minor cuts to muscle aches.
The safety advice for either product is straightforward: use the smallest amount that does the job, apply only to intact or minimally broken skin as directed, and keep all topical anesthetics locked away from children. That last point deserves extra emphasis for dibucaine given its track record in pediatric poisoning cases. A tube of hemorrhoid ointment does not look dangerous, but for a small child who puts it in their mouth, dibucaine can be lethal in quantities that might seem trivially small to an adult. Lidocaine products are not safe for children to ingest either, but the larger margin of safety means accidental exposure is less likely to be catastrophic.
Neither drug requires a prescription for topical use in the United States, though the concentrations available over the counter are lower than what a physician might prescribe or administer. If your pain is severe enough that over-the-counter topical anesthetics are not cutting it, the answer is not to use more product or apply it more often. The answer is to see a clinician who can evaluate what is going on and, if needed, provide a different approach to pain management.